A researcher has developed a new device for assisted reproductive technology that can quickly, easily and cost effectively select only the healthiest sperm without causing DNA damage.
FAU researchers have developed a group of proteins called tissue inhibitors of metalloproteinases designed as specific inhibitors of selected MMP targets that could potentially treat osteoarthritis and cancer.
Waseem Asghar, Ph.D. received the award for his work on developing a new diagnostic biosensing platform that could be used to remotely detect and determine treatment options for HIV and other diseases.
FAU's Charles E. Schmidt College of Medicine has received initial accreditation for residency programs in general surgery and emergency medicine, in collaboration with its member teaching hospitals.
Professors have evaluated the totality of evidence and conclude that regular physical activity has the closest resemblance to a "magic bullet" to fight the epidemic of obesity and cardiovascular disease.
Randy D. Blakely, Ph.D., a renowned neuroscientist and leading expert in synaptic pharmacology, neurotransmitter transporters, and neurogenetics, is at the helm of the newly-formed FAU Brain Institute.
Olga Bakina, a Fulbright scholar from the Ukraine, received her M.S. in biomedical science at FAU's graduation ceremony this morning. Bakina will be pursuing a Ph.D. at Helmholtz Zentrum in Munich, Germany.
FAU's College of Medicine celebrated a long-anticipated day as it conferred the Doctor of Medicine (M.D.) degrees to 61 members of the class of 2016, making them the nation's newest physicians.
There are currently no medications available to specifically treat Lewy Body dementia (LBD). FAU's College of Medicine is spearheading the South Florida site for the first U.S. clinical trial for LBD.
Inspired by pregnancy tests, scientists have developed a method to store microfluidic devices for months without refrigeration, giving developing countries an inexpensive and reliable way to treat patients.